A Phase 2 Trial of the Aurora Kinase A Inhibitor MLN8237 in Patients with Metastatic Castrate Resistant and Neuroendocrine Prostate Cancer
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Weill Medical College of Cornell University
Start Date
November 1, 2013
End Date
October 31, 2019
Administered By
Duke Cancer Institute
Awarded By
Weill Medical College of Cornell University
Start Date
November 1, 2013
End Date
October 31, 2019